Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer

NCT01084057 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: vorinostat
DRUG: ixabepilone
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

City of Hope Medical Center